Quality-of-life outcomes and measurement in childhood atopic dermatitis
about
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsCyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids.Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges.Mental health associations with eczema, asthma and hay fever in children: a cross-sectional survey.Atopic dermatitis burden scale: creation of a specific burden questionnaire for families.New insights in the pathogenesis of atopic dermatitis.The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.Conceptualisation, development and validation of T-QoL© (Teenagers' Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases.Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator-blinded, controlled study.Parents' experience of childhood atopic eczema in the public health sector of Gauteng.Educational background of nurses and their perceptions of the quality and safety of patient care.Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Efficacy of Omalizumab therapy in a case of severe atopic dermatitis.Children hospitalised with bronchiolitis in the first year of life have a lower quality of life nine months later.Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.Guidelines for the management of atopic dermatitis (eczema) for pharmacists.Amelioration of the progression of an atopic dermatitis-like skin lesion by silk peptide and identification of functional peptides
P2860
Q28086973-15B81C3B-6E4E-4707-8009-F9BF1B13B493Q34006054-487F2771-F8BF-4E0F-A44F-CBC366205BDBQ35628612-60F86BE3-7C70-47C5-BB31-84E027A5403EQ35928377-9F3F4B80-CAD6-4697-96BF-8CF7271E15D8Q37355887-ED3A2076-8A3D-481D-A6EE-C02E91C2166CQ38107026-D34A9397-2C69-4D17-8BF1-A1E842DDF13AQ38160151-6D568AD9-84E7-40D4-9B13-2059BA486761Q38597139-CF2A6CE8-5F67-4151-A624-EF7AB031ADBBQ38649988-35697793-EC82-454F-87A2-4DF9BDCF8824Q40484107-5729CBEC-302F-44D1-8111-222334585B10Q40896724-A55AC5F1-7729-4C00-98CA-C4C376842C50Q40897896-3E123C26-B7D9-45F8-8755-6AC9C9654E6EQ41435416-3E16090D-E0CC-4FEA-86BE-6916C3A930D2Q46089253-B5DE75AC-5434-4390-8D08-AD2AD7D54574Q48066782-D13E40D9-4961-46A4-8EA8-D639203F22B9Q48087641-31A60E51-B862-40C3-AA4E-135D54143C2EQ50144719-E332B66F-0E69-43D6-874A-EFFC1FF1A795Q57218265-86CA2C97-7C15-4360-A6E5-041CAE592D80
P2860
Quality-of-life outcomes and measurement in childhood atopic dermatitis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@ast
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@en
type
label
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@ast
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@en
prefLabel
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@ast
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@en
P2860
P1476
Quality-of-life outcomes and measurement in childhood atopic dermatitis
@en
P2093
Mary-Margaret Chren
Sarah L Chamlin
P2860
P304
P356
10.1016/J.IAC.2010.05.004
P577
2010-07-01T00:00:00Z